MI
Mohammed Irfan
About Mohammed Irfan
Data last updated:
Mohammed Irfan is a Director at Revivewell Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Revivewell Pharmaceuticals Private Limited reported revenue of ₹15.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revivewell Pharmaceuticals Private Limited U46497TS2023PTC175962 | Director | 11 Aug 2023 | 2023 | ₹15.9 Lakh (FY 2025) | Active |
Board colleagues of Mohammed Irfan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sri Ramachandra Murthy Kolavennu | 10276050 | Revivewell Pharmaceuticals Private Limited | Director |
| Tambali Suvarna | 10276048 | Revivewell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammed Irfan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammed Irfan
Mohammed Irfan currently holds 1 directorship: Revivewell Pharmaceuticals Private Limited (Director, since 11 Aug 2023, revenue ₹15.9 Lakh (FY 2025)).
Mohammed Irfan was first appointed on 11 Aug 2023 as Director at Revivewell Pharmaceuticals Private Limited.
The current boards of Mohammed Irfan's companies include Sri Ramachandra Murthy Kolavennu (Revivewell Pharmaceuticals Private Limited), Tambali Suvarna (Revivewell Pharmaceuticals Private Limited).